Eva Comperat

Summary

Country: France

Publications

  1. ncbi request reprint Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis
    Eva Comperat
    Service d Anatomie Pathologique, Hopital Pitie Salpetriere, Boulevard de l Hopital, 75013 Paris, France
    Arch Pathol Lab Med 131:965-9. 2007
  2. doi request reprint Different subtypes of carcinoma in situ of the bladder do not have a different prognosis
    Eva Comperat
    Department of Pathology, hôpital La Pitié Salpêtrière, Assistance Publique Hopitaux de Paris, Université Pierre et Marie Curie University Paris VI, 47 83, Bd de l Hopital, 75013 Paris, France
    Virchows Arch 462:343-8. 2013
  3. doi request reprint Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases
    Eva Comperat
    Service d Anatomie et Cytologie Pathologique et Service d Urologie, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Pathology 42:650-4. 2010
  4. ncbi request reprint Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer
    Eva Comperat
    Service d anatomie et cytologie pathologique, hôpital La Pitié Salpêtrière, Paris, France
    Urol Int 82:312-7. 2009
  5. doi request reprint Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience
    Evanguelos Xylinas
    Department of Urology, GHU EST Pitié Tenon, Assistance Publique Hopitaux de Paris, Paris, France
    BJU Int 103:1173-8; discussion 1178. 2009
  6. doi request reprint Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer
    Eva Comperat
    CNRS UMR 8149, Faculte de Pharmacie, Paris V, Paris, France
    Urology 72:873-7. 2008
  7. ncbi request reprint Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma
    Eva Comperat
    Pathologic Anatomy Service and Urology Service, hôpital La Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, Parie, Frances
    Anal Quant Cytol Histol 32:39-44. 2010
  8. doi request reprint Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage
    Justine Varinot
    Department of Pathology, Pitie Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France
    Virchows Arch 455:449-53. 2009
  9. doi request reprint Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours
    David R Yates
    Academic Department of Urology and Pathology of la Pitié Salpêtrière, Tenon Hospital, Groupe Hospitalo Universitaire EST, Assistance Publique, Hopitaux de Paris, Faculte de Medecine Pierre et Marie Curie, University Paris VI, Paris, France
    World J Urol 31:53-9. 2013
  10. doi request reprint Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy
    Eva Comperat
    ER2, University PMC Paris VI, CeRePP, Paris, France
    Prostate 70:1622-7. 2010

Detail Information

Publications63

  1. ncbi request reprint Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis
    Eva Comperat
    Service d Anatomie Pathologique, Hopital Pitie Salpetriere, Boulevard de l Hopital, 75013 Paris, France
    Arch Pathol Lab Med 131:965-9. 2007
    ..Splenic metastases occur in a context of multivisceral disseminated cancer or as a solitary lesion...
  2. doi request reprint Different subtypes of carcinoma in situ of the bladder do not have a different prognosis
    Eva Comperat
    Department of Pathology, hôpital La Pitié Salpêtrière, Assistance Publique Hopitaux de Paris, Université Pierre et Marie Curie University Paris VI, 47 83, Bd de l Hopital, 75013 Paris, France
    Virchows Arch 462:343-8. 2013
    ..5955, respectively). Pathologists need not include different subtypes of primary CIS in their report as there is no difference in patient outcomes. It is important to recognize all different subtypes as CIS for best patient treatment...
  3. doi request reprint Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases
    Eva Comperat
    Service d Anatomie et Cytologie Pathologique et Service d Urologie, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Pathology 42:650-4. 2010
    ..It is unknown if any amount of a micropapillary component justifies the diagnosis of MPC. It is also unknown if surface MPC also has aggressive potential...
  4. ncbi request reprint Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer
    Eva Comperat
    Service d anatomie et cytologie pathologique, hôpital La Pitié Salpêtrière, Paris, France
    Urol Int 82:312-7. 2009
    ..Our series explores protein expression of markers known to be indicators of poor clinical outcome and progression, trying to explain aggressiveness of MPC...
  5. doi request reprint Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience
    Evanguelos Xylinas
    Department of Urology, GHU EST Pitié Tenon, Assistance Publique Hopitaux de Paris, Paris, France
    BJU Int 103:1173-8; discussion 1178. 2009
    ..To determine the effectiveness of cancer control afforded by radical prostatectomy (RP) in patients with clinical stage T3 prostate cancer...
  6. doi request reprint Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer
    Eva Comperat
    CNRS UMR 8149, Faculte de Pharmacie, Paris V, Paris, France
    Urology 72:873-7. 2008
    ..We wanted to gain better insight into the early molecular mechanisms of bladder carcinogenesis by evaluating Aurora-A gene expression, which is implicated in genomic stability and essential for mitosis...
  7. ncbi request reprint Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma
    Eva Comperat
    Pathologic Anatomy Service and Urology Service, hôpital La Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, Parie, Frances
    Anal Quant Cytol Histol 32:39-44. 2010
    ..To explore Foxp3, a member of the forkhead box family of transcription factors, which is a major gene for regulatory T (Treg) cell development of CD4+CD25+ or CD8+CD25+ phenotype...
  8. doi request reprint Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage
    Justine Varinot
    Department of Pathology, Pitie Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France
    Virchows Arch 455:449-53. 2009
    ..Data are similar to those published in the recent literature, where whole mount sections were used. This protocol also permits better detection of concomitant prostate carcinomas...
  9. doi request reprint Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours
    David R Yates
    Academic Department of Urology and Pathology of la Pitié Salpêtrière, Tenon Hospital, Groupe Hospitalo Universitaire EST, Assistance Publique, Hopitaux de Paris, Faculte de Medecine Pierre et Marie Curie, University Paris VI, Paris, France
    World J Urol 31:53-9. 2013
    ..Herein, we evaluate a bladder-UC cohort to see whether similar polymorphisms are linked similarly same way with disease risk and aggressiveness...
  10. doi request reprint Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy
    Eva Comperat
    ER2, University PMC Paris VI, CeRePP, Paris, France
    Prostate 70:1622-7. 2010
    ..Genetic polymorphism located within the IL16 gene has been reported to be associated with aggressive prostate cancer (PCa). Our aim was to establish whether the tissue expression of IL16 is a prognostic factor of survival in PCa...
  11. ncbi request reprint Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
    Sylvia Scarpini
    Academic Pathology Department, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Urol Oncol 30:182-7. 2012
    ..To investigate whether overexpression of p53, MIB-1, and Aurora-A on protein level played a role in the relapse of urothelial carcinomas of the upper urinary tract (UC-UUT)...
  12. doi request reprint Comparison of mid-term carcinologic control obtained after open, laparoscopic, and robot-assisted radical prostatectomy for localized prostate cancer
    Sarah J Drouin
    Department of Urology, GHU Est, Assistance Publique Hopitaux de Paris, Faculte de Medecine Pierre et Marie Curie, Pitie Salpetriere Hospital, University Paris VI, Paris, France
    World J Urol 27:599-605. 2009
    ..To determine the cancer control afforded by radical prostatectomy in patients who underwent either an open, laparoscopic, or robotic procedure for localized prostate cancer...
  13. ncbi request reprint Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination
    Evanguelos Xylinas
    Department of Urology, Pitie Salpetriere, Assistance Publique Hopitaux de Paris, 47 83 boulevard de l Hopital, 75013, Paris, France
    World J Urol 31:881-6. 2013
    ..To assess the value of dynamic contrast-enhanced magnetic resonance imaging (MRI) for the prediction of extracapsular extension (ECE) in patients with clinical T3 (cT3) prostate cancer (PCa) compared to digital rectal examination (DRE)...
  14. doi request reprint Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm
    Matthieu Peycelon
    Department of Urology, Groupement Hospitalier Universitaire Est Pitié Tenon, Assistance Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France
    J Urol 181:35-41. 2009
    ..We determined the cancer control provided by nephron sparing surgery for renal cell carcinoma greater than 4 cm...
  15. doi request reprint Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy
    David R Yates
    Faculte de Medecine Pierre et Marie Curie, Academic Department of Urology of la Pitiè Salpétriére Hospital, Assistance Publique Hopitaux de Paris, University Paris VI, 75013 Paris, France
    Prostate 72:1382-8. 2012
    ....
  16. doi request reprint Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience
    Kien Nguyen
    Department of Urology of Pitié Salpétrière Hospital, GHU Est, Assistance Publique Hopitaux de Paris, Faculte de Medecine Pierre et Marie Curie, University Paris VI, 75013 Paris, France
    World J Urol 27:653-8. 2009
    ..To assess the cancer control afforded by radical prostatectomy (RP) in patients with prostate-specific antigen (PSA) values above 20 ng/ml...
  17. doi request reprint Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience
    François Audenet
    The Academic Department of Urology, Pathology and Statistics of La Pitié Salpétrière, Groupe Hospitalo Universitaire EST, Assistance Publique Hopitaux de Paris, Paris, France
    Urol Oncol 29:602-7. 2011
    ..To assess the oncologic control afforded by radical prostatectomy (RP) in high-risk prostate cancers with a Gleason score ≥ 8...
  18. doi request reprint Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy
    Sarah J Drouin
    Department of Urology of GHU EST, Assistance Publique Hopitaux de Paris, Paris, France
    Urol Oncol 30:402-7. 2012
    ..To analyze clinical characteristics and pathologic findings in patients eligible for active surveillance (AS) who underwent radical prostatectomy (RP)...
  19. doi request reprint HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin
    Justine Varinot
    Laboratoire Oncotype Urologie GRC UPMC 05, Hopital de la Pitie Salpetriere, Paris, France
    Virchows Arch 463:803-9. 2013
    ..These results justify testing of HOXB13 as a prostate-specific carcinoma marker in larger cohorts for a more thorough evaluation of its sensitivity and specificity...
  20. doi request reprint [International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]
    Eva Comperat
    Service d anatomie et cytologie pathologique, hôpital La Pitié Salpêtrière, UPMC Paris VI, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Ann Pathol 33:155-61. 2013
    ..This review summarizes the conclusions and recommendations resulting from the consensus process. ..
  21. doi request reprint Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review
    Morgan Roupret
    Academic Departments of Urology, Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    J Urol 189:2069-76. 2013
    ..Predictive factors of T1 nonmuscle invasive bladder cancer evolution that could guide treatment decision making are lacking. We assessed the prognostic value of muscularis mucosa invasion in nonmuscle invasive bladder cancer...
  22. ncbi request reprint The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience
    Morgan Roupret
    Department of Urology, Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, France
    Can J Urol 19:6459-64. 2012
    ..Accurate staging at the time of primary TURBT, including the presence of DM, is crucial to avoid understaging and unnecessary delay in definitive treatment...
  23. ncbi request reprint p63 gene expression study and early bladder carcinogenesis
    Eva Comperat
    CNRS UMR 8149, Faculté de Pharmacie Paris V, Paris, France
    Urology 70:459-62. 2007
    ....
  24. doi request reprint Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study
    Alexandra Masson-Lecomte
    The Academic Department of Urology, Pathology and Statistics of La Pitié Salpétrière, Groupe Hospitalo Universitaire EST, Assistance Publique Hopitaux de Paris, 47 83 bvd de l hopital, 75013 Paris, France
    World J Urol 29:665-70. 2011
    ..To assess pathological findings and oncological control afforded by radical prostatectomy (RP) in high-risk prostate cancers (PCa) at our institution...
  25. ncbi request reprint Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping
    Olivier Belas
    Department of Urology, Pitie Salpetriere Hospital, GHU Est, Assistance Publique Hopitaux de Paris, Paris, France
    Can J Urol 19:6366-72. 2012
    ..To determine the accuracy of a 12-core biopsy protocol in assessing the location of prostate tumors within radical prostatectomy (RP) specimens...
  26. doi request reprint Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer
    Vincent Misrai
    Department of Urology of Pitié Salpétrière Hospital, Groupe Hospitalo Univeristaire EST, Assistance Publique Hôpitaux de Paris Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France
    World J Urol 26:481-5. 2008
    ..To assess the long term oncologic results of high-intensity focused ultrasound therapy (HIFU) as a primary and single treatment for clinically localized prostate cancer...
  27. doi request reprint Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses
    François Audenet
    AP HP, Academic Urology Department, Pitie Salpetriere Hospital, 83 bvd de l Hôpital, 75013, Paris, France
    World J Urol 32:513-8. 2014
    ..The aim of the study was to assess the outcome after nephron-sparing surgery (NSS) of patients with small renal masses (SRMs) who would have been eligible for active surveillance (AS)...
  28. doi request reprint The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy
    Sarah J Drouin
    Service d Urologie, Hopital Pitie Salpetriere, AP HP, 83 Bvd Hopital, 75013, Paris, France
    World J Urol 32:489-93. 2014
    ..To assess the surgical approach using the pathological specimen obtained after open radical prostatectomy (ORP) or robot-assisted radical prostatectomy (RALRP)...
  29. doi request reprint Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study
    Raphaele Renard-Penna
    Academic Department of Radiology, La Pitié Salpêtrière, Groupe Hospitalo Universitaire EST, Assistance Publique Hôpitaux de Paris Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France
    Urol Oncol 31:448-54. 2013
    ..To evaluate the role of pelvic phased array MRI in staging prostate cancer (CaP)...
  30. doi request reprint Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur
    François Audenet
    The Academic Department of Urology, Pathology and Statistics of La Pitié Salpétrière, Groupe Hospitalo Universitaire EST, Assistance Publique Hopitaux de Paris, 47 83 bvd de l hopital, 75013 Paris, France
    World J Urol 30:239-44. 2012
    ..To determine the prognostic factors of biochemical recurrence in patients who failed to achieve an undetectable prostate-specific antigen (PSA) after radical prostatectomy (RP) for prostate cancer...
  31. doi request reprint [Benign mimickers of the prostate cancer. Diagnostic challenges]
    Eva Comperat
    Service d Anatomie Pathologique, hôpital La Pitié Salpêtrière, UMPC Paris VI, Paris, France
    Ann Pathol 33:237-46. 2013
    ..The above entities can in some instances simulate low-grade and less commonly high grade PCa. Knowledge of these patterns and application of appropriate immunohistochemistry will lead the pathologist to a correct diagnosis...
  32. doi request reprint Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis
    Morgan Roupret
    Academic Department of Urology and Pathology, Groupe Hospitalo Universitaire EST, Assistance Publique Hopitaux de Paris, Paris, France
    J Urol 187:424-8. 2012
    ..A polymorphism located at the T allele of rs9642880 on chromosome 8q24 is linked to an enhanced risk of bladder tumors. We explored the association of this polymorphism with susceptibility to upper urinary tract urothelial carcinoma...
  33. ncbi request reprint Prostate cancer with clear cell features and an unusual nested-like pattern of growth: a case report
    Justine Varinot
    Public Assistance Hospital of Paris, Department of Pathology, La Pitie Salpetriere Hospital, University UPMC Paris VI, Paris, France
    Anal Quant Cytol Histol 34:289-92. 2012
    ..Clear cell carcinoma of the prostate is rare, with the majority of reports consisting of a single case study...
  34. ncbi request reprint Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processing
    Pierre Mozer
    Department of Urology, Assistance Publique Hopitaux de Paris, Paris, France
    J Ultrasound Med 28:455-60. 2009
    ....
  35. doi request reprint Molecular and histological markers in urothelial carcinomas of the upper urinary tract
    Stephanie Eltz
    Academic Department of Urology of la Pitié Salpêtrière and Tenon Hospital, Paris, France
    BJU Int 102:532-5. 2008
    ..Therefore a subgroup of patients with a higher risk of recurrence could be identified as well as patients that could benefit from minimal invasive surgery...
  36. doi request reprint Prostate needle biopsy examination by means of virtual microscopy
    Cyrus Chargari
    Department of Oncology and Radiotherapy, Val de Grâce Hospital, Paris, France
    Pathol Res Pract 207:366-9. 2011
    ..23, marginal agreement) to 66.2% for virtual slide examination (κ=0.42, good agreement). Virtual microscopy does not compromise, but might improve, the accuracy of grading in prostate needle biopsies. This requires further assessment...
  37. ncbi request reprint [Can a standard treatment be proposed for penile cancer?]
    Jean Nicolas Cornu
    Services d urologie, l Hôpital Pitie Salpêtrière, Paris, France
    Prog Urol 17:1347-50. 2007
    ..Malignant tumours of the penis are rare and their management is complex. The objective of this study was to review the management and report the results based on a personal series...
  38. doi request reprint Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer
    Olivier Cussenot
    CeRePP, Tenon Hospital, Paris, France
    Clin Cancer Res 14:5635-9. 2008
    ..Recently, two independent loci located at 8q24 that contribute to prostate cancer risk in men of European origin were identified...
  39. doi request reprint Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy
    Morgan Roupret
    Department of Urology, Groupe Hospitalo Universitaire EST, Pitie Salpetriere, Paris, France
    BJU Int 104:813-7; discussion 817-8. 2009
    ..To establish the predictive accuracy of the Kattan preoperative nomogram by comparing predictions at 5 years with actual progression in patients who had a radical prostatectomy (RP)...
  40. doi request reprint European guidelines on upper tract urothelial carcinomas: 2013 update
    Morgan Roupret
    Department of Urology, Groupe Hospitalier Pitie Salpetriere, Assistance Publique Hopitaux de Paris, Faculty of Medicine Pierre et Marie Curie, Institut Universitaire de Cancérologie GRC5, University Paris 6, Paris, France
    Eur Urol 63:1059-71. 2013
    ....
  41. doi request reprint Poorer outcome in Polynesian patients with prostate cancer treated with definitive conformational radiation therapy
    Antonin Levy
    Department of Radiation Oncology, Pitie Salpetriere University Hospital, Paris, France
    Radiother Oncol 101:502-7. 2011
    ..To compare freedom from biochemical failure (FFBF) of French Polynesian (FP) and Native European (NE) prostate cancer patients after definitive conformal radiotherapy (RT)...
  42. ncbi request reprint Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases
    Eva Comperat
    Service Central d Anatomie et Cytologie Pathologiques et d Urologie, hôpital La Pitié Salpêtrière, 83, Bd de l Hopital, 75013 Paris, France
    Virchows Arch 448:319-24. 2006
    ..A statistical difference disserving pTa and pT1/>or=pT2 with a statistical significance (p<10(-6)) could also be observed. P63 should be considered as an additional biomarker that might help pathologists to classify their patients...
  43. doi request reprint Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder
    Véronique Phé
    Department of Urology, AP HP, Pitié Salpêtrière Academic Hospital, Pierre et Marie Curie Medical School, Paris VI University, Paris, France
    Urology 81:1108.e1-6. 2013
    ..To assess the involvement of connexins (Cxs) 43 and 45 in the selective inhibition of detrusor contractions in patients with neurogenic detrusor overactivity (NDO)...
  44. doi request reprint Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum
    Morgan Roupret
    Hopital Pitie Salpetriere, Academic Urology Department, 47 83 boulevard de l Hopital, 75013 Paris, France
    Eur Urol 54:1226-36. 2008
    ..The data describing the urologic extracolonic cancers associated with hereditary nonpolyposis colorectal cancer (HNPCC) are variable...
  45. ncbi request reprint Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin
    Eva Comperat
    Service d Anatomopathologique de l Hôtel Dieu, Place du Parvis Notre Dame, Paris, France
    Mod Pathol 18:1371-6. 2005
    ..01). These results suggest that the diagnostic virtue of TTF-1 detection depends on the used antibody's clone. The SPT24 clone seems to have a stronger affinity for TTF-1 protein but may lead to a few positive colorectal adenocarcinomas...
  46. doi request reprint An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
    Justine Varinot
    Service d Anatomie Pathologique, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Int J Surg Pathol 19:285-9. 2011
    ..The authors describe a pigmented renal tumor occurring in a 30-year-old woman with distinct morphology and immunohistochemical characteristics as Xp11 translocation renal cancer...
  47. ncbi request reprint [Bladder cancer in neurological patients: analysis of a single-centre series]
    Jérôme Parra
    Services d urologie, Hopital Pitie Salpetriere, Paris, France
    Prog Urol 17:1333-6. 2007
    ..To report the prevalence, aetiologies and course of bladder cancer in our population of neurological patients...
  48. ncbi request reprint Fluorescence diagnosis and flat lesions of urothelium: new challenges for pathologists and urologists (Review)
    Eva Comperat
    Service d Anatomie Pathologique, hôpital La Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, Paris VI, France
    Oncol Rep 21:839-44. 2009
    ..How far can we go in our answer as pathologists and how will it change the patient management?..
  49. ncbi request reprint [Left paravesical cystic urothelial tumour: an exceptional case?]
    Stéphane Leroux
    Service d Urologie, GH Pitié Salpétrière, Paris, France
    Prog Urol 16:208-10. 2006
    ..In view of the unusual histology, comprising carcinoma in situ and a transitional cell papillary tumour with metastatic lymph node extension, the authors reviewed the literature on this subject and identified only one similar case (5)...
  50. ncbi request reprint Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia
    Eva Comperat
    Service d Anatomie et de Cytologie Pathologiques, Hotel Dieu, Paris, France
    Arch Pathol Lab Med 130:1227-30. 2006
    ..The Epstein-Barr virus-positive lymphoproliferation can be accounted for by the type of immunosuppression induced by the treatment...
  51. doi request reprint An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps
    Eva Comperat
    Department of Pathology, Groupe Hospitalier La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Histopathology 63:756-66. 2013
    ..We aimed to generate a teaching set of images based on the diagnostic opinions of a panel of expert genitourinary pathologists...
  52. doi request reprint Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experience
    Guillaume Legrand
    Academic Department of Urology, Assistance Publique Hopitaux de Paris, University Paris VI, Paris, France
    Urology 78:937-41. 2011
    ..To assess the outcome of cutaneous noncontinent urinary diversion (CNCUD) for neurogenic bladder management in multiple sclerosis (MS) patients...
  53. ncbi request reprint Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A
    Eva Comperat
    Service d anatomie et cytologie pathologique, Hopital de la Pitie Salpetriere, Universite Paris VI, France
    Eur Urol 50:1058-64. 2006
    ..To study histological features and morphological differences in bladder wall specimen from patients with and without botulinum toxin A injections and to compare those issues in responders and non-responders to the toxin therapy...
  54. ncbi request reprint Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis
    Eva Comperat
    Service d anatomie et cytologie pathologique, Hopital La Pitie, Paris, France
    Urol Int 78:86-8. 2007
    ..This case suggests that splenic metastasis might be the result of the growth of an early blood-borne micrometastasis within the spleen after a period of clinical latency...
  55. ncbi request reprint [Sensory innervation of the bladder: clinical and therapeutic implications]
    Eva Comperat
    Service d anatomie et cytologie pathologique, Hopital de la Pitie Salpetriere, Faculte de Medecine Pierre et Marie Curie, Université Paris VI Paris, France
    Prog Urol 17:5-11. 2007
    ....
  56. doi request reprint Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance
    Marie Dominique Azémar
    Department of Urology, Pitié Salpêtrière and Tenon Hospitals, GHU Est, AP HP, Faculte de Medecine Pierre et Marie Curie, University Paris VI, Paris, France
    Urol Oncol 29:130-6. 2011
    ..To highlight the main risk factors for metachronous bladder recurrence after treatment of an upper urinary tract urothelial cell carcinomas (UUT-UCCs) based on the recent literature...
  57. ncbi request reprint Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes
    Josee Audouin
    Service central Jacques Delarue d Anatomie et de Cytologie Pathologiques, Hotel Dieu, Paris, France
    Br J Haematol 122:404-12. 2003
    ..Transformation into DLBCL occurred in 11 of 34 patients. The patterns described are not specific for PSMZL and occur also in primary nodal MZL and, more rarely, in MALT-type lymphoma...
  58. ncbi request reprint Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1
    Xavier Leroy
    Department of Pathology, University Hospitals CHRU, Lille, France University Lille Nord de France, Lille, France
    Histopathology 64:1032-6. 2014
    ..The objective of this study was to document the clinicopathological and immunohistochemical characteristics of CCPRCC, with a special emphasis on cyclin D1 expression...
  59. doi request reprint Human papillomavirus is not an etiologic agent of urothelial inverted papillomas
    Riley E Alexander
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Am J Surg Pathol 37:1223-8. 2013
    ..Our findings indicate the absence of HPV in urothelial inverted papillomas. HPV testing should not be used as a diagnostic adjunct for inverted papilloma cases. ..
  60. doi request reprint Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome
    Roger Mouawad
    AP HP, Salpetriere Hospital, University of Pierre and Marie Curie Paris 6, Laboratory of the Medical Oncology Department, 47 Boulevard de l Hopital, 75013 Paris, France
    Eur J Cancer 45:1407-14. 2009
    ....
  61. ncbi request reprint Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases
    Eva Comperat
    CNRS UMR 8149, and Service d Anatomie Pathologique, Centre Hospitalier Universitaire Bicêtre, Paris, France
    Urol Int 76:269-73. 2006
    ..EGF-r function and proliferative activity in cyst formation in PKD remains to be explored. EGF-r and Ki-67 expressions are not predictive of development of carcinoma in PKD...
  62. pmc Renal angiomyolipoma associated with inferior vena cava thrombus
    Xavier Durand
    Department of Urology, Pitie Salpetriere University Hospital, 75013, Paris, France
    Case Report Med 2009:789078. 2009
    ..Intravascular extension into the IVC of angiomyolipoma has rarely been reported. We present a new case and reconsider the literature about this uncommon complication of a benign renal tumor...
  63. ncbi request reprint Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature
    Sophie Ferlicot
    Service d Anatomie Pathologique, Hopital de Bicetre, Paris, France
    Virchows Arch 447:978-83. 2005
    ..Further investigations are required to determine the frequency and true prognosis of these tumors, which are easily identifiable morphologically...